Mannkind (MNKD) Return on Invested Capital (2014 - 2026)

Mannkind's (MNKD) quarterly Return on Invested Capital came in at 0.0% in Q1 2026, down 10.56% on a QoQ basis from 0.0% in Q4 2024.

Mannkind (MNKD) Return on Invested Capital (2014 - 2026) Analysis & Trends

Mannkind (MNKD) has 8 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2026.

On a quarterly basis, Return on Invested Capital changed N/A year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a N/A change from a year earlier, with the FY2023 full-year figure at 0.0%, changed N/A from the prior year.
Return on Invested Capital for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
Over the last five years, Return on Invested Capital for MNKD reached as high as 0.0% in Q4 2024 and fell as low as 0.0% in Q1 2022.
Historically, Return on Invested Capital has averaged 0.0% across 4 years, with a median of 0.0% in 2024.
On a YoY basis, Return on Invested Capital climbed as much as 0 bps in 2024 and fell as far as 0 bps in 2024.
Year by year, Return on Invested Capital stood at 0.0% in 2022, then soared by 108 bps to 0.0% in 2023, then surged by 1654 bps to 0.0% in 2024, then decreased by 11 bps to 0.0% in 2026.
Per Business Quant data, the three most recent Return on Invested Capital figures were 0.0% in Q1 2026, 0.0% in Q4 2024, and 0.0% in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.00%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.04%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Mannkind	1.20 Bn	1.07 Bn	82.66 Mn	0.00%

Download Data